On February 23, 2024, The MIT Sloan Healthcare Club convened the 22nd annual MIT Sloan Healthcare and Bioinnovations Conference.
Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
New Frontiers in Interoperability and Data Exchange With FHIR
Krikor Dzeronian, EMBA' 20, and Jason Lavender, EMBA '20, are co-founders of Electives, a B2B SaaS startup launched after the two students met in the MIT Executive MBA.
The MIT Sloan Health Systems Initiative discovers transformative and sustainable innovations that improve health by engaging world-class researchers with health systems leaders.
As the horrors of the Russian invasion of Ukraine played out in front of millions around the globe, five MIT EMBA alumni decided to step in and help. Here’s how they used knowledge gained directly from the program, to developing frameworks to solve some of the country’s most pressing issues.
Dr. Michael Solomon completed the MIT EMBA program, and his son, Samuel, completed his bachelor’s degree.
Christine Hofbeck, EMBA '16, is an actuary, keynote speaker, and author of Winning Conditions: How to Achieve the Professional Success You Deserve by Managing the Details That Matter.
Rick Kanner, EMBA '19, is Senior Director of Oncology Market Access at Eli Lilly in Indianapolis, IN.
Adam Szaronos, EMBA '18, is the Chief Commercial Officer at TearLab Corporation, located in Fort Worth, TX.
